Featured Research

from universities, journals, and other organizations

Researchers focus on role of the protein progerin in atherosclerosis in both modern and ancient times

Date:
July 30, 2014
Source:
World Heart Federation
Summary:
Since evidence of atherosclerosis has been discovered in ancient human mummies, attention has been focused on possible causative factors other than those related to modern lifestyles. Researchers now discuss the potential role of the protein progerin.

Since evidence of atherosclerosis (hardening of the arteries) has been discovered in ancient human mummies, attention has been focused on possible causative factors other than those related to modern lifestyles. In a paper in this month's Global Heart (the journal of the World Heart Federation), researchers discuss the potential role of the protein progerin. The paper is by Dr Michael Miyamoto, Mission Heritage Medical Group, St. Joseph Heritage Health, Mission Viejo, CA, USA, and colleagues.

Clues to these processes may possibly be found in accelerated aging syndromes, such as Hutchinson-Gilford progeria syndrome (HGPS), an ultra-rare disorder characterised by premature aging, including very aggressive forms of atherosclerosis, occurring in childhood. The genetic defect in HGPS eventuates in the production of a mutant form of the nuclear structural protein lamin A, called progerin, which is thought to interfere with normal functioning of blood vessels.

Progerin appears to be expressed in vascular cells, resulting in vessel wall cell loss and replacement by fibrous tissue, impairing vessel function and promoting calcification, leading to the vascular dysfunction and atherosclerosis seen in HGPS. Interestingly, vascular progerin is detectable in lower levels, in an age-related manner, in the general population, providing the basis for further study of the potential role of abnormal forms of lamin A in the atherosclerotic process of normal aging.

The authors ask: "As HGPS patients and many of the ancient humans in the Horus Study demonstrate atherosclerosis without intense exposure to conventionally accepted vascular risk factors, could they together provide insight into the biological processes that more generally contribute to the development of age-related vascular disease?"

They add: "The observations of severe vascular disease occurring at a very young age in HGPS patients and the detection of progerin in non-HGPS coronary artery disease together suggest that at least a part of an inherent human predisposition to atherosclerosis may be attributable to the vascular effects of progerin and/or other abnormal lamin A forms. That such a basic human propensity to the disease exists should not be surprising, perhaps. Clinically, the occurrence of serious disease states related to atherosclerosis, such as acute coronary and stroke syndromes, is not uncommonly observed in modern patients lacking obvious vascular risk factors. In explaining these patients' situations, medical providers often vaguely cite complex genetic risk, 'bad luck', or other, unrecognised factors. It is tempting to speculate that age-related vascular progerin production may be a specific, possibly even major, example of such factors."

From the observations in this paper, the authors propose a paradigm of atherosclerosis, in four parts:

1) The development of atherosclerosis in humans is an inexorable process, perhaps in part related to progressive, age-related progerin and/or other abnormal lamin A expression and accumulation.

2) Atherosclerosis remains clinically silent, until it reaches a threshold burden of disease (flow-limiting stenosis or blockage of the blood vessels) and/or disease activity (plaque rupture and thrombosis).

3) The background rate of the development of atherosclerosis may be accelerated to varying degrees by multiple factors, many of which may be interrelated, including modern vascular risk factors (e.g., sedentary lifestyles, obesity, tobacco use, hypertension, metabolic abnormalities), chronic infections/inflammation (perhaps particularly relevant to ancient peoples), and genetic predispositions that have been found to be associated with higher risk of clinical vascular disease.

4) Effective risk factor management and medical therapies may retard the progression of atherosclerosis, reducing or delaying the risk of reaching a threshold level of disease or disease activity associated with clinical disease manifestations.

The Horus Team plan to probe for the presence of progerin in ancient human mummy tissue samples, and, if detectable, to evaluate possible correlations of age and protein expression, as well as progerin detection and radiographic signs of atherosclerosis.

Dr Miyamoto concludes: "It is perhaps ironic that humans living thousands of years ago, as well as modern children suffering an extremely rare genetic disease may together help to shed light on some of the fundamental processes that underlie one of the most common diseases of modern humans. If, from such investigations, our understanding of vascular disease is significantly advanced, perhaps forming the basis for novel preventive treatments, we will owe a debt of gratitude to both these ancient peoples and those with HGPS."


Story Source:

The above story is based on materials provided by World Heart Federation. Note: Materials may be edited for content and length.


Cite This Page:

World Heart Federation. "Researchers focus on role of the protein progerin in atherosclerosis in both modern and ancient times." ScienceDaily. ScienceDaily, 30 July 2014. <www.sciencedaily.com/releases/2014/07/140730203709.htm>.
World Heart Federation. (2014, July 30). Researchers focus on role of the protein progerin in atherosclerosis in both modern and ancient times. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2014/07/140730203709.htm
World Heart Federation. "Researchers focus on role of the protein progerin in atherosclerosis in both modern and ancient times." ScienceDaily. www.sciencedaily.com/releases/2014/07/140730203709.htm (accessed October 23, 2014).

Share This



More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins